High dividend-paying stocks are down 7% this year versus gains of 9% and 26% for the S&P 500 and Nasdaq, respectively. Now, it is time for investors to prepare for them to rebound,...
Gilead Sciences, Inc. (Nasdaq: NASDAQ:GILD) today announced that Cindy Perettie will join the company as Executive Vice President of Kite, a Gilead Company, overseeing the cell...
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more...
A federal jury rules against the agency’s patent grab for the company’s HIV treatment.
Stagflation remains one of the primary risks for the global economy in 2023. The stock market’s trajectory will continue to be dictated by worries over persistently high...
The daily chart looks pretty strong right now. The stock is trying to break through the resistance line that started around the beginning of December.
Gilead Sciences, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of medicine to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company’s products for HIV/AIDS patients include Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, and Stribild. The Company’s COVID-19 product is Veklury. The Company’s also provides Epclusa, Harvoni, Vemlidy, and Viread products for liver diseases. The products under hematology/oncology/cell therapy include Yescarta, Tecartus, Trodelvy, and Zydelig. The Company’s other products include Letairis (ambrisentan), Ranexa (ranolazine), Cayston, Jyseleca, and AmBisome (amphotericin B liposome for injection). The Company also sells and distributes generic versions of Epclusa and Harvoni in the United States. The Company is also focused on restoring immune balance with agonists targeting immune inhibitory receptors.
| Average | 91.61 (+18.83% Upside) |
| High | 115.00 |
| Low | 77.00 |
| Price | 77.09 |
| No. of Analysts | 23 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Buy |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 54.60 | 54.80 | 54.00 | +0.50 | +0.92% | 655.15K | London | |||
| 9.95 | 9.50 | 9.50 | -0.45 | -4.52% | 20.69K | London | |||
| 656.00 | 663.80 | 654.20 | +3.40 | +0.52% | 433.37K | London | |||
| 14.30 | 14.30 | 14.30 | -0.05 | -0.35% | 500.04K | London | |||
| 5.50 | 5.50 | 5.50 | 0.00 | 0.00% | 0.00 | London | |||
| 111.80 | 112.00 | 109.40 | +0.80 | +0.72% | 73.90K | London | |||
| 2.85 | 2.85 | 2.85 | 0.00 | 0.00% | 3.95K | London | |||
| 295.00 | 295.00 | 281.00 | 0.00 | 0.00% | 0.00 | London | |||
| 8.70 | 8.82 | 8.70 | -0.25 | -2.78% | 1.22M | London | |||
| 1,147.00 | 1,147.00 | 1,147.00 | 0.00 | 0.00% | 0.00 | London | |||
| 335.00 | 335.00 | 335.00 | 0.00 | 0.00% | 0.00 | London | |||
| 9.62 | 9.62 | 9.62 | 0.00 | 0.00% | 11.00 | London | |||
| 37.13 | 37.13 | 37.13 | -0.11 | -0.29% | 50.75K | London | |||
| 1,180.00 | 1,190.00 | 1,155.00 | +10.00 | +0.85% | 18.58K | London | |||
| 197.40 | 197.40 | 193.00 | +0.40 | +0.20% | 658.18K | London |